Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer

European Radiology

Volumn 19, Issue 6, 2009, Pages 1529-1536

  Kitajima, Kazuhiro ^a,b   Murakami, Koji ^a   Yamasaki, Erena ^a   Kaji, Yasushi ^a   Sugimura, Kazuro ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

FDG; Lymphnode metastasis; PET CT; Uterine cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINATED CONTRAST MEDIUM; IOMEPROLE 300; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOMETRIUM CANCER; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MALE; PARAAORTIC LYMPH NODE METASTASIS; PELVIC LYMPH NODE METASTASIS; PELVIS LYMPHADENECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; UTERUS CANCER;

ADULT; AGED; AORTA; AORTOGRAPHY; CARCINOMA; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PELVIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; SYSTEMS INTEGRATION; TOMOGRAPHY, X-RAY COMPUTED; UTERINE NEOPLASMS;

EID: 67349120990     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-1271-8     Document Type: Article

References (35)

1. International Federation of Gynecology and Obstetrics (1995) FIGO staging of gynecologic cancers. Int J Gynecol Cancer 5:319-324
2. Manetta A, Delgado G, Petrilli E, Hummel S, Barnes W (1986) The significance of paraaortic node status in carcinoma of the cervix and endometrium. Gynecol Oncol 23:284-290
3. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer. Cancer 60:2035-2041
4. Inoue T, Morita K (1990) The prognostic significance of number of positive nodes in cervical carcinoma stageIB, IIA, and IIB. Cancer 65:1923-1927
5. Gal D, Recio FO, Zamurivic D, Tancer ML (1991) Lymphovascular space involvement. A prognostic indicator in endometrial adenocarcinoma. Gynecol Oncol 42:142-145
6. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC (1991) Carcinoma of the cervix treated with radiation therapy: A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67:2776-2785
7. Lai CH, Hong JH, Hsueh S et al (1999) Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcome of stageIB and II cervical carcinoma patients with or without pelvic lymph-node metastases: An analysis of 891 cases. Cancer 85:1537-1546
8. Chan JK, Cheung MK, Huh WK et al (2006) Therapeutic role of lymph node resection in endometrioid corpus cancer: A study of 12,333 patients. Cancer 107:1823-1830
9. Hricak H, Rubinstein LV, Gherman GM, Karstaedt N (1991) MR imaging evaluation of endometrial cancer: Results of an NCI cooperative study. Radiology 179:829-832
10. Sugiyama T, Nishida T, Ushijima K et al (1995) Detection of lymph node metastasis in ovarian carcinoma and uterine corpus carcinoma by preoperative computerized tomography or magnetic resonance imaging. J Obstet Gynaecol 21:551-556
11. Connor JP, Andrews JI, Anderson B, Buller RE (2000) Computed tomography in endometrial cancer. Obstet Gynecol 95:692-696
12. Manfredi R, Mirk P, Maresca G et al (2004) Local-regional staging of endometrial carcinoma: Role of MR imaging in surgical planning. Radiology 231:372-378
13. Rockall AG, Sohaib SA, Harisinghani MG et al (2005) Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23:2813-2821
14. Rockall AG, Meroni R, Sohaib SA et al (2007) Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 17:188-196
15. Kim SH, Kim SC, Choi BI, Han MC (1994) Uterine cervical carcinoma: evaluation of pelvic lymph node metastases with MR imaging. Radiology 190:807-811
16. Scheidler J, Hricak H, Yu KK, Subak L, Segal MR (1997) Radiological evaluation of lymph node metastases in patients with cervical cancer: A meta-analysis. JAMA 278:1096-1101
17. Hawighorst H, Schoenberg SO, Knapstein PG et al (1998) Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MR imaging with a phased-array coil in comparison with pathological findings. J Comput Assist Tomogr 22:75-81
18. Yang WT, Lam WH, Yu MY, Cheung TH, Metreweli C (2000) Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol 175:759-766
19. Reinhardt MJ, Ehritt-Braun CD, Vogelgesang D et al (2001) Metastatic lymph nodes in patients with cervical cancer: Detection with MR imaging and FDG PET. Radiology 218:776-782
20. Choi HJ, Roh JW, Seo SS et al (2006) Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma. Cancer 106:914-922
21. Cook GJ, Maisey MN, Fogelman I (1999) Normal variants, artifacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 26:1363-1379
22. Kostakoglu L, Agress Jr H, Goldsmith SJ (2003) Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23:315-340
23. Beyer T, Townsend DW, Brun T et al (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369-1379
24. Bar-Shalom R, Yefremov N, Guralnik L et al (2003) Clinical performance of PET/CT in evaluation of cancer: Additional value for diagnostic imaging and patient management. J Nucl Med 44:1200-1209
25. Sironi S, Buda A, Picchio M et al (2006) Lymph node metastasis in patients with clinically early stage cervical cancer: Detection with integrated FDG PET/CT. Radiology 238:272-279
26. Loft A, Berthelsen AK, Roed H et al (2007) The diagnostic value of PET/ CT scanning in patients with cervical cancer: A prospective study. Gynecol Oncol 106:29-34
27. Park JY, Kim EN, Kim DY et al (2008) Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 108:486-492
28. Kitajima K, Murakami K, Yamasaki E et al (2008) Accuracy of FDG PET/CT in detecting pelvic and paraortic lymph node metastasis in patients with endometrial cancer. AJR Am J Roentgenol 190:1652-1658
29. Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV, Wahl RL (1999) Evaluation of FDG PET in patients with cervical cancer. J Nucl Med 40:1125-1131
30. Suzuki R, Miyagi E, Takahashi N et al (2007) Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer. Int J Gynecol Cancer 17:890-896
31. Sachs S, Bilfinger TV, Komaroff E, Franceschi D (2005) Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer. Cancer 6:310-313
32. Kidd EA, Siegel BA, Dehdashti F, Grigsby PW (2007) The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 110:1738-1744
33. Shimoda W, Hayashi M, Murakami K, Oyama T, Sunagawa M (2007) The relationship between FDG uptake in PET scans and biological behavior in breast cancer. Breast Cancer 14:260-268
34. Harisinghani MG, Barentsz J, Hahn PF et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491-2499
35. Harada T, Tanigawa N, Matsuki M, Nohara T, Narabayashi I (2007) Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur J Radiol 63:401-407